UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)
<div class="breadcrumb breadcrumbs"><div class="breadcrumb-trail"> » <a href="https://epims.med.ubc.ca" title="UBC PiMS Research Group (the Tremlett Laboratory)" rel="home" class="trail-begin">Home</a> <span class="sep">»</span> <a href="https://epims.med.ubc.ca/research/" title="Research">Research</a> <span class="sep">»</span> <a href="https://epims.med.ubc.ca/research/presentations/" title="Conference Presentations">Conference Presentations</a> <span class="sep">»</span> ACTRIMS 2023 </div></div>

ACTRIMS 2023

Gastrointestinal Conditions in the Multiple Sclerosis Prodrome.

Authors: F.L.A. Yusuf, F. Zhu, C. Evans, J.D. Fisk, Y. Zhao, R.A. Marrie, H. Tremlett.

Session 1; #P183; Abstract #736

Presentation Type: Poster Presentation

Risk of Multiple Sclerosis in People with HIV: An International Cohort Study

E. Kingwell, A. Manouchehrinia, F. Zhu, K. McKay, J. Li, M. Ye, P. Sereda, J. Trigg, K. Kooij, M. Gisslén, A. Ekström, J. Hillert, R. Hogg, H. Tremlett.

Presentation Type: Oral Presentation – Session 3 – Impact of COVID-19 and Other Pathogens on MS ( https://www.abstractsonline.com/pp8/#!/10822/presentation/48)

Media coverage

HIV-positive people found to be less likely to develop MS (posted March 1st 2023): https:// multiplesclerosisnewstoday.com/news-posts/2023/03/01/actrims-2023-hiv-positive-people-less-likely- develop-ms-study/ 

Understanding the Risk of Multiple Sclerosis in Patients with HIV (posted March 28th 2023):  https://www.neurologylive.com/view/understanding-the-risk-of-multiple-sclerosis-patients-with-hiv

 

Psychiatric Morbidity in Multiple Sclerosis During the Prodromal Period

Authors: A. Chertcoff, F. L. Yusuf, F. Zhu, C. Evans, J. D. Fisk, Y. Zhao, R. Marrie, H. Tremlett.

Presentation Type: Oral Presentation.

The American Academy of Neurology (in partnership with the Americas Committee for Treatment and Research in MS) Annual Meeting in Boston, MA, April 22 – 27, 2023.

Awards:

ACTRIMS Educational Grant as a Young Investigator with a highly rated abstract accepted for oral presentation. The Educational Grant includes a $600 USD stipend to use in support of participation at the ACTRIMS Forum 2023.

National MS Society’s ECHO MS Continuing Education scholarship, $US1500 for travel

Selected by ACTRIMS as a Best Young Investigator Oral Presentation Finalist

Media coverage:

High Level of Psychiatric Morbidity in Prodromal MS Medscape Neurology interview, posted 27 Feb 2023 ( https://www.medscape.com/viewarticle/988845)

Anxiety, depression more common in MS before onset  https://multiplesclerosisnewstoday.com/news-posts/2023/02/24/actrims-2023-psychiatric-symptoms-may-predate-ms-onset-5-years/

Psychiatric visits 146% higher for patients in year before MS onset https://www.healio.com/news/neurology/20230224/ psychiatric-visits-146-higher-for-patients-in-year-before-ms-onset

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia